Landscape Summary:
Blood-brain barrier permeability changes as early biomarkers for neurodegeneration is a 0.9 priority gap in neurodegeneration.
It has 0 linked hypotheses with average composite score 0.506.
Status: investigating.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
Blood-brain barrier permeability changes as early biomarkers for neurodegeneration — INVOKE-2 (completed)